|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00648 SOFTMEDX-NEW
Nominal 
0.380 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 51,340 | 52.051% | 33,765 | 1,699 | 9,617 | 40,157 |
| Cost of Sales | (30,215) | 50.864% | (20,028) | (909) | (4,392) | (16,866) |
| Gross Profit | 21,125 | 53.782% | 13,737 | 790 | 5,225 | 23,291 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (1,987) | |
| Change in FV & Impairment on Others | -- | -- | (494) | (4,075) | (5,043) | (23,896) | |
| Profit / (Loss) on Disposal | (4,725) | -- | -- | -- | 647 | 230 | |
| Other Non-operating Items | 19,075 | -- | (1,070) | 7,949 | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 14,369 | -- | (16,632) | (24,717) | (52,470) | (79,217) | |
| Taxation | (1,858) | -28.346% | (2,593) | 0 | 0 | 85 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | (1,558) | 1,624 | 2,148 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 12,511 | -- | (19,225) | (26,275) | (50,846) | (76,984) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 12,577 | -18.916% | 15,511 | 16,268 | 18,101 | 16,887 |
| Depreciation & Amortisation | 1,189 | -41.716% | 2,040 | 1,194 | 1,572 | 7,015 |
| Directors' Emoluments | 215 | -98.304% | 12,679 | 12,794 | 12,999 | 12,999 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Disclaimer | Disclaimer | Disclaimer |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 3.800 | -- | -5.900 | -8.100 | -15.600 | -23.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.014) | -- | (0.009) | (0.020) | (0.030) | (0.050) |
| NBV per share ($) | (0.993) | -- | (1.032) | (0.973) | (0.893) | (0.737) |
| Remarks: | Real time quote last updated: 06/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -6,093,000 |
| %Change | 57.279% |
| EPS / (LPS) | HKD -0.019 |
| NBV Per Share ($) | HKD -1.012 |